Nobel Award Honors Groundbreaking Body's Defenses Discoveries

This year's Nobel Prize in Physiology or Medicine was granted for transformative findings that illuminate how the body's defense network attacks harmful pathogens while protecting the body's own cells.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this accolade.

Their work identified specialized "security guards" within the defense system that eliminate rogue immune cells capable of attacking the organism.

These findings are now paving the way for new therapies for autoimmune diseases and cancer.

The winners will divide a prize fund valued at 11 million Swedish kronor.

Decisive Findings

"The work has been essential for comprehending how the immune system operates and why we don't all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

The team's studies explain a core question: In what way does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

The body's protection system employs white blood cells that scan for indicators of infection, including pathogens and bacteria it has not met before.

Such cells utilize detectors—called recognition units—that are produced randomly in a vast number of combinations.

That gives the immune system the ability to combat a wide array of threats, but the unpredictability of the process unavoidably produces immune cells that may attack the body.

Protectors of the Body

Researchers previously understood that some of these harmful defense cells were eliminated in the thymus—the site where immune cells develop.

This year's award recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to neutralize other defenders that attack the healthy cells.

We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "The discoveries have established a novel area of investigation and spurred the development of innovative treatments, for instance for cancer and immune disorders."

Regarding malignancies, T-regs block the system from attacking the tumor, so studies are focused on lowering their numbers.

For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the body is not being harmed. A comparable approach could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, from a Japanese institution, conducted tests on rodents that had their thymus extracted, causing autoimmune disease.

The researcher showed that injecting immune cells from other animals could stop the illness—implying there was a mechanism for preventing defenders from harming the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in rodents and humans that resulted in the identification of a genetic factor critical for the way regulatory T-cells function.

"The groundbreaking work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a leading physiology specialist.

"This research is a striking illustration of how basic biological research can have broad implications for human health."